We have studied the effect of intraperitoneal nitroprusside on small (urea) and middle (vitamin B12) molecule dialysis clearances in patients maintained on chronic peritoneal dialysis. Clearances were measured in six patients during the addition of 6 mg of nitroprusside to three and seven consecutive, hourly two-liter exchanges during the course of a routine dialysis treatment. Results indicate that clearances of urea and B,2 both increased about 35 percent with the addition of the vasodilator for three exchanges. Clearances immediately returned to baseline values when administration of the vasodilator was discontinued. Addition of the drug to seven consecutive exchanges resulted in a sustained 35 percent increment in clearances.
INTRODUCTION
During the past few years, maintenance peritoneal dialysis has been utilized increasingly as a therapeutic modality for patients with end-stage renal disease. A major limitation of this therapy is the long duration of treatment required to achieve satisfactory clinical results [1] . Attention has been focused, therefore, on finding ways to increase the rates of solute removal and thus perhaps decrease the time required for maintenance dialysis therapy [2] [3] [4] [5] [6] . For example, the intraperitoneal instillation of vasodilators during peritoneal dialysis has been clearly shown to result in significant increments in small molecular clearances in patients [2] and both small and middle molecule clearances in laboratory animals [4] .
The present study was undertaken to obtain data on the effect of intraperitoneal nitroprusside on small and middle molecule clearances in patients maintained on chronic peritoneal dialysis. Previous studies in the rat [4] demonstrate a proportional increase of small and middle size molecules. While Nolph has reported an increase in small molecule clearances in patients treated with intraperitoneal nitroprusside [14] , a systematic evaluation of middle size molecules has not been performed. Since molecules in the 300-5000 dalton range may be important mediators of uremia, this study was undertaken to measure the effect of intraperitoneal nitroprusside on middle molecule clearances. While other vasodilators have been used in experimental dialysis including isoproterenol [3] , hydralazine [2] , phentolamine [2] , dopamine [3] , histamine [4] , and bradykinin [4] , nitroprusside has been demonstrated to be safe in humans and was chosen for study. Specifically, dialysis clearances of urea (MW 60) and vitamin B12 (MW 1350) Commercially available bottled 1.5 percent dextrose dialysate (Travenol) was used throughout the study and maintained at 370 C by a constant temperature bath. Onehour exchanges of 2 liters each were used. Each peritoneal clearance determination was made with an exchange consisting of 10 minutes' inflow time, 30 minutes' dwell time, and 20 minutes' drain time, as described previously [7] [8] [9] . Exchanges were considered to be technically acceptable for clearance calculations if the 2000 ml inflow was achieved in ten minutes, there was no significant leakage of fluid about the catheter exit site, and dialysate return measured 1900-2300 ml.
At the start of each dialysis a blood sample was collected and analyzed for B,2 binding protein [10, 11] . Previous studies [7] indicated that the level of B12 binding protein did not change during the course of an individual peritoneal dialysis. 0.5 mg of vitamin B12 was then given intramuscularly; this amount was found to give plasma B,2 levels that exceeded the level of plasma B,2 binding protein by a factor of four to ten for the duration of dialysis.
Blood samples were obtained at the midpoint of each clearance period. At the end of each exchange, the drainage bag was vigorously shaken and an aliquot of dialysate was obtained. Blood and dialysate samples were analyzed for urea [12] , and B12 concentrations [13] .
Urea and vitamin B12 clearances were calculated using the standard formula [5] C= clearance (ml/ min) Cd x Vd t x Cb where Cd = concentration of solute in dialysis drainage fluid, Vd = volume of dialysis drainage fluid, t = time of one exchange, Cb = concentration of solute in serum during the exchange. In the clearance calculation the level of B12 binding protein, and hence bound B12, was subtracted from the total level of serum B12. B12 binding protein in dialysate was found to be unmeasurable and hence all of the B12 in the dialysate was considered unbound. As previously reported [7] , recovery rates of vitamin B12 from 1.5 percent dextrose dialysate were between 95 percent and 105 percent over the range of dialysate B12 concentrations observed in the study.
Since previous studies by our group have shown that from the seventh to the thirtysixth exchange clearances with hourly 1.5 percent dextrose dialysate exchanges remain constant [7] , the effect of instillation of intraperitoneal nitroprusside on clearances was studied during eight consecutive exchanges after the sixth exchange using two protocols. Each of the six patients was studied with both protocols within a two-week period of time. In Protocol A, 6 mg nitroprusside was added to exchanges 3-5 and no drug was added to exchanges 1-2 and 6-8 (Table 1) . In Protocol B, 6 mg nitroprusside was added to exchanges 3 to 8 and no drug was added to exchanges 1-2 (Table 1) . Period II is defined as exchanges 3 to 5. The sixth exchange is regarded as a that had been perfused either intermittently or not at all [14] . Thus, nitroprusside may increase the endothelial area available for peritoneal transfer by increasing the total area of arterioles and capillaries perfused. The proportional increment in small and middle molecule clearances in response to intraperitoneal nitroprusside noted in a rat model of peritoneal dialysis supports this hypothesis [4] . Similarly, in the present study the increments in urea and B12 clearances were both about 35 percent. However, the interpretation of this proportional increase is complicated by the possible limitations imposed in the urea clearance by the dialysate flow rate of 33 ml/ min.
Previous studies of Nolph et al. [14] , in which the effects of intraperitoneal nitroprusside on peritoneal dialysis clearances in patients were examined, reported an increment of about 20 percent in small molecule clearances with the addition of the vasodilator. However, clearances of inulin, which were determined in only one patient, increased over 200 percent during the addition of 9 mg of nitroprusside to nine consecutive two-liter exchanges. This large increase in the clearance of inulin was associated with a 63 percent increment in the calculated mass transfer coefficient for inulin. In the present study the percent increment in clearances of larger sized molecules was not as marked as observed by Nolph. Differences between the present study and Nolph's report include the measurement of vitamin B12 (MW = 1350) clearances versus inulin (MW = 5200) clearances, and the dose of nitroprusside used (6 mg versus 9 mg per two liters of dialysate).
The effect of intraperitoneal nitroprusside on urea and inulin peritoneal dialysis clearances in the rat [4] is similar to that observed in the present study. The only difference is that, in the rat model, the increased clearances persist during the three exchanges following the discontinuation of nitroprusside administration. A major difference between the rat and patient studies is the duration of each exchange: 15 minutes in the rat and 60 minutes in the patients. Perhaps the effect of nitroprusside on dilating capillaries and arterioles is of sufficient duration to cause persistently increased clearances in the protocol used in the rat studies but not of sufficient duration to result in increased clearances in period III of protocol A in the present study.
In summary, the addition of 6 mg of nitroprusside to peritoneal dialysis solution can result in a significant increment in small and middle molecule clearances. Maintenance of the higher clearances requires sustained administration of the drug, which can be tolerated for at least six exchanges with no adverse side effects.
